The expression of HLA-DR antigens by normal myeloid progenitor cells (CFU-GM) has been linked to inhibition of colony growth by prostaglandin E (PGE), while resistance to the inhibitory effects of PGE in chronic myeloid leukemia (CML) has been attributed to a lower fraction of HLA-DR+ CFU-GM in this disease. However, we have previously shown that virtually all CFU-GM in normal bone marrow (NBM) as well as CML peripheral blood express HLA-DR antigens, which raises the possibility that these surface molecules may not be the sole determinants of a progenitor cell's sensitivity to PGE. In order to evaluate the relationship between HLA-DR expression and prostaglandin inhibition, we partially purified NBM progenitor cells using fluorescence-activated cell sorting to prepare cell fractions with high and low HLA-DR antigen density. Normal progenitor cells with high DR density tended to form monocyte colonies in agar culture, whereas the low DR density fraction was enriched for granulocyte colony-forming cells. Inhibition by PGE was greatest in the high DR+ fraction and was largely restricted to monocyte progenitor cells. Inhibition of CFU-GM by PGE was less in CML than in NBM, but this decreased inhibition correlated with a significantly lower number of monocyte-CFU ii CML. These data suggest that high HLA-DR antigen density may select for normal progenitor cells that are committed to monocyte differentiation and are, therefore, more likely to be inhibited by PGE. The relative deficit of monocyte progenitor cells in CML may partially explain the phenomenon of PGE resistance in this disease.
Introduction
HLA-DR antigens are expressed on a variety of hematopoietic cells including B cells, activated T cells, monocytes, and progenitor cells of the erythroid and myeloid lineages (1) (2) (3) (4) (5) (6) . These Ia-like antigens regulate cellular interactions of the immune response, but their role in the regulation of hematopoiesis is less clear (7-10). Recent reports have suggested that the inhibitory effects of acidic isoferritins or prostaglandin E (PGE)' on the normal granulocyte/monocyte colony-forming cell (CFU-GM) appear to be restricted to those cells that express HLA-DR (1 1, 12) . This is of particular interest because it has been reported that the fraction of DR+ CFUJ-GM in chronic myeloid leukemia (CML) is lower than in normal bone marrow (NBM), and this has been linked to the resistance of CML progenitor cells to PGE (12, 13) .
Different laboratories have varied widely in their determinations of the fraction of normal and CML CFU-GM that express HLA-DR, however, and the association of DR expression with sensitivity to PGE has not been universally accepted (14) . It is possible that the extent to which CFU-GM are detected as DR+ may depend on the anti-DR antibody used and its capacity to fix complement, and thus CFU-GM with low DR antigen density would be negative in some studies and weakly positive in others. Unfortunately, complement lysis of CFU-GM is not an ideal technique to investigate DR antigen density, and little is known about biological or functional differences that exist between CFU-GM with low density or high density DR expression.
Previous studies in our laboratory and others with flow cytometry have shown that virtually all CFU-GM of both NBM and CML are DR+, and that the range of Ia antigen density is extremely broad (15, 16) . In this report we describe the use of cell-sorting techniques to prepare populations ofCFU-GM with different levels ofDR antigen expression. These populations have been characterized functionally and used to examine the relationship of DR antigen density to PGE sensitivity. The results indicate that subsets of day 7 CFU-GM express different levels of HLA-DR depending upon their commitment to monocyte or granulocyte differentiation. High density DR+ CFUJ-GM were enriched for monocyte progenitor cells, and these cells were more sensitive to PGE inhibition compared with granulocyte progenitor cells.
A parallel investigation of progenitor cell subsets and PGE sensitivity in NBM and CML was also done. Sensitivity to PGE inhibition was related to the proportion of monocyte progenitor cells present in either NBM or CML. The observation that overall inhibition by PGE tended to be less in CML may be partly a result of a relative deficiency of monocyte precursor cells in this disease.
Methods
Source ofCFU-GMs. Peripheral blood samples (5-10 ml) were obtained from stable-phase CML patients undergoing initial diagnostic testing. forming cell; CML, chronic myeloid leukemia; FACS, fluorescence-activated cell sorting; FCS, fetal calf serum; G/M, granulocyte/monocyte; GCT, giant cell tumor conditioned medium; IMDMEM, Iscove's modified Dulbecco's minimal essential media; MEM, minimal essential me-After collection into sterile-heparinized syringes, the mononuclear cell fraction was separated by Ficoll-Hypaque diatrizoate gradient sedimentation, washed twice in minimal essential media (MEM; Gibco, Grand Island, NY) containing 2.5% pooled human AB serum (MEM-AB wash), and cryopreserved in the vapor phase of liquid nitrogen in 10% dimethylsulfoxide and 203% heat-inactivated fetal calf serum (FCS) until use. Samples were thawed in the presence of 100 jsg/ml deoxyribonuclease I (Worthington Biochemical Corp., Freehold, NJ) to minimize cell agglutination. Two CML samples were studied before cryopreservation with equivalent results.
NBM was aspirated from healthy volunteers into heparinized syringes after written consent was approved by the Institutional Review Board. The mononuclear cell fraction was separated by Ficoll-Hypaque diatrizoate gradient sedimentation as above.
Monoclonal antibodies. Monoclonal antibodies used in the purification of CML colony-forming cells have been previously characterized and include anti-MY8 (pan-myeloid) (17) , anti-Mol (pan-myeloid) (18) , anti-Mo2 (monocyte) (18) , anti-B 1 (B cell) (19) , anti-T3 and anti-Tl 1 (T cell) (20, 21) , HNK1 (natural killer cell) (22) , and 31C6 (basophil and natural killer cells) (Hercend, T., and J. Griffin, unpublished observation). Monoclonal antibodies used in the purification of NBM were similar, but also included an anti-glycophorin A monoclonal antibody (clone 39, Sabbath, K., and J. Griffin, unpublished observation).
Partial purification of myeloid progenitor cells. The method of myeloblast purification from the peripheral blood ofCML patients has been previously reported and has also been applied to the partial purification of normal bone marrow CFU-GM (23) . Briefly, 1-2 X 10' mononuclear cells from either NBM or CML peripheral blood were incubated with the previously noted monoclonal antibodies for 30 min at 4VC. After two wash steps, affinity-purified rabbit anti-mouse immunoglobulin coupled to sheep erythrocytes by chromic chloride was added (0.7 ml of 10% vol/vol erythrocytes in MEM-AB wash per 10' cells). The erythrocyte-mononuclear cell mixture was pelleted (800 g, 10 min) and incubated at 4°C for 20 min for rosette formation. The rosetted cells were then separated from the nonrosetted cells (containing the progenitor cells) by density gradient sedimentation. Interface cells (unrosetted) were washed twice in MEM-AB. A cytocentrifuge preparation was examined to determine purity.
For CML peripheral blood, this technique typically resulted in a preparation of 85-95% blast forms with a colony-forming efficiency (CFU-GM) of 30-40%. For NBM, partial purification usually resulted in a preparation of -30-50% blasts, 50% promyelocytes, 0-10% myelocytes, and 0-10% early erythroid precursors, with a CFU-GM colonyforming efficiency of 10-20%. For some experiments, monocytes were prepared from fresh peripheral blood by adherence as previously described ( 15) .
Immunofluorescence analysis ofHLA-DR. In order to determine the relationship of HLA-DR expression to CFU-GM commitment, partially purified progenitor cells from NBM were stained for DR antigen expression by an indirect immunofluorescence assay and subsequently sorted on the basis of HLA-DR antigen density. Briefly, I X 107 partially purified cells were washed twice in MEM-AB wash, and the pellet was then suspended in 1.0 ml of diluted ascites. Monoclonal antibody 9-49, which identifies a monomorphic DR determinant (24) , was used as a 1:250 dilution of ascites for these experiments ( Liquid suspension culture. In order to exclude the possibility that the growth, differentiation, and staining characteristics of NBM and CML CFU-GM were altered by in vitro agar culture, partially purified NBM and CML peripheral blood were also grown in liquid suspension culture over a 7-14-d period. For each treatment group, I X 106 partially purified progenitor cells were suspended in 5 ml of IMDMEM, 20% FCS, 10%
GCT (Gibco), 1o-6 M indomethacin, with or without I0' M PGEI in a 60 X 15-mm petri dish (Falcon Laboratories, Oxnard, CA) on day 0. On days 7 and 14 of culture (370C, 5% CO2), the cell population was counted, and cytocentrifuge smears were stained for combined esterase activity and with Wright-Giemsa stain.
Statistical analysis. Significance levels for comparison between treatment groups were determined using two-sided t tests. Paired tests were used when appropriate. Significance levels for correlations were derived from the t test conversion on the correlation coefficient r. The association between monocyte colony number and overall PGE inhibition was estimated by standard multiple regression techniques (26).
Results
Relationship ofHLA-DR expression to CFU-GM commitment. In order to investigate the relationship between PGE inhibition and HLA-DR antigen expression, partially purified progenitor cells from NBM were separated into two fractions on the basis ofHLA-DR antigen density by fluorescence-activated cell sorting (FACS) and assayed for CFU-GM in agar, with or without 10-6 M PGE,. In pilot experiments, it was shown that >95% ofCFU-GM are recovered in the DR+ fraction. Because of the small numbers ofCFU-GM present in the DR-fraction, further analysis of that fraction was not undertaken. Colonies and clusters were counted on day 7 using combined esterase staining to detect monocyte colonies (ANAE+, CAE-) granulocyte colonies (ANAE-, CAE+), and mixed G/M (granulocyte/monocyte) colonies (ANAE+, CAE+). A typical FACS-I histogram of HLA-DR (9-49) expression in this cell population is shown in Fig. 1 , and data from five experiments with different bone marrow donors are presented in Table I . In each case, both the absolute number and the relative percentage of pure monocyte colonies was greater in the high HLA-DR antigen group of CFU-GM. The mean percentage of monocyte colonies was significantly greater for the high density HLA-DR group (36±13 vs. 3±3%, P < 0.005), as was the mean percentage of mixed G/M plus monocyte colonies (47±19 vs. 1 1±10%, P < 0.005).
Relationship of HLA-DR expression to PGE inhibition. In four ofthe five sorting experiments, the inhibitory effects of 10-6 M PGE, on day 7 CFU-GM were assessed (Table II) . In each case, the overall inhibition by PGEI was greater in the high DR antigen density group, with the mean PGEI inhibition being 37±8% for the high density and 4±13% for the low density DR+ progenitor cells (p = 0.025). The inhibitory effects of PGE, on individual CFR-GM subsets, however, appeared to be similar for both DR density groups, with the greatest degree ofinhibition being observed for monocyte colonies, a moderate degree of inhibition for mixed G/M colonies, and the least amount of inhibition (and sometimes slight enhancement) for granulocyte colonies.
Despite the similar response of CFU-GM subsets in either DR+ fraction to 10-6 M PGE1, we considered the possibility that the dose response of colony inhibition at lower PGEI concentrations may differ between the low and high DR+ groups. In order to evaluate this possibility, sorted cells were plated in the presence of PGEI in a dose range of I0-6-I0-o M, and the results of one such experiment are shown in Table III . As in previous experiments, high density HLA-DR+ CFU-GM were inhibited to a substantially greater degree than were low density HLA-DR+ CFR-GM. This inhibition was restricted to monocyte and mixed CFR-GM. However, when CFU-GM subsets were analyzed individually, the degree of colony inhibition was similar for the low and high DR+ groups over a broad range of PGEI concentrations. It should be noted that accurate quantitation of monocyte progenitor cell inhibition by PGE in the low density DR+ fraction was limited by the extremely low number of monocyte colonies in this group (Table III) .
Comparison of CFU-GM subsets in NBM and CML. The experiments described above suggested that inhibition of normal CFU-GM by PGE was partly determined by the proportion of CFR-GM committed to monocyte differentiation, and that the association between PGE sensitivity and DR expression could be due to the fact that monocyte-CFU expressed higher levels of DR antigen than granulocyte-CFI. In order to test this observation further, we evaluated the composition of CFR-GM subsets and their sensitivity to PGE in CML, a disease which is characterized by resistance to PGE inhibition despite the presence of HLA-DR on the majority of CFU-GM (15) .
Partially purified progenitor cells from NBM and CML peripheral blood were evaluated for colony and cluster formation on days 7 and 14, with the cumulative results of 18 experiments shown in Table IV Table V and Fig. 2 . As expected, 10-6 M PGE, markedly inhibited pure monocyte colony and cluster formation in NBM, but it also effectively inhibited pure monocyte colony-forming cells (CFU) in CML. For example, PGE1 inhibition of NBM monocyte colonies and clusters at day 7 was 95±10% (n = 8), compared with 89±21% (n = 8) for CML (Table V) . The inhibition of mixed colony and cluster formation by PGE1 was substantial for both NBM and CML, though generally less than the inhibition observed for pure monocyte colonies. Granulocyte colonies and clusters were generally resistant to the inhibitory effects of PGE1 in both NBM and CML. Overall colony and cluster inhibition by PGE,, however, was less in CML compared with NBM on both days 7 (13±12 vs. 32±8%, P = 0.01) and day 14 (31±10 vs. 43±13%, P = 0.2).
Although the degree of inhibition of CFU-G`M subsets was similar for NBM and CML at 10 M PGE1, it was possible that differences in the pattern of colony inhibition may become apparent at lower PGEI concentrations. To evaluate this possibility, the inhibiting effects of 10, 10-8, and 10-10 M PGE1 were tested, with the data from two representative experiments shown in Table VI . For NBM, the inhibition of ANAE+ colonies (mixed GM plus monocyte) by 106, 10-, and 10-10 M PO;E was 82±4, 63±6, and 28±1 1%, respectively (n = 2). Corresponding data for CML revealed inhibition of 96±6, 81 ± 17, and 50±17%, respectively (n = 3). However, the low number of monocyte colonies in these CML cases does not allow us to conclude with certainty that CML monocyte progenitor cells are as sensitive to PGE as are NBM progenitor cells. The inhibition of granulocyte colonies was negligible for both groups over this PGE, dose range.
These data suggest that overall colony inhibition by PGE may be partly determined by the initial percentage of ANAE+ (Table VII) . As expected, PGE, resulted in a reduction in the percentage of macrophages for both NBM and CML suspension cultures at days 7 and 14.
Discussion
The detection of HLA-DR surface molecules on hematopoietic progenitor cells has created considerable interest, particularly with the finding ofan association between DR antigen expression by CFU-GM and the in vitro growth regulation of these cells by inhibitory factors such as acidic isoferritins or PGE (11, 12) . Further, the insensitivity of CML CFU-GM to the inhibitory effects ofPGE, has been related to a lower amount of DR antigen as detected by complement lysis techniques (12, 13) . By using more sensitive assay techniques, however, we (15, 17, 23) and others (16) have found that virtually all CFU-GM from both NBM and CML peripheral blood express detectable levels of DR antigen, making it unlikely that DR antigen expression is the sole determinant of CFU-GM sensitivity to PGE. In this report, we have investigated the possibility that high HLA-DR antigen density on myeloid progenitor cells, rather than the expression of HLA-DR per se, identifies a subset of CFU-GM that is sensitive to the inhibitory effects of PGEI. Partially purified myeloid progenitor cells from NBM were separated by cell sorting into two fractions on the basis of HLA-DR antigen density, and CFU-GM subsets were determined by ANAE and CAE staining of agar cultures. Partial purification of NBM progenitor cells provided an enriched population of DR+ cells (-30% HLA-DR+), and thus facilitated sorting of CFU-GM on the basis of DR antigen density. Furthermore, partial purification of CFU-GM also minimized the possible effects of accessory cells (monocytes, T lymphocytes) in the inhibition of colony growth by PGEI.
Analysis of day 7 colonies and clusters revealed a significant Table V (27) (28) (29) , an association between high HLA-DR density and commitment to monocyte differentiation has not been previously described.
It should be noted that these data do not exclude the possibility that HLA-DR antigen density may be functionally important in the mediation of prostaglandin colony inhibition, independent of monocyte progenitor cell enrichment. However, the fact that no major difference was demonstrated in the PGEmediated inhibition of different CFU-GM subsets in either the high or low HLA-DR groups suggests that DR antigen density may not independently define a progenitor cell's sensitivity to inhibition by PGE. Nevertheless, in view of the difficulty in accurately quantitating the degree of PGE inhibition of monocyte colonies in the low DR density fraction (due to low numbers of monocyte progenitor cells in control cultures), we cannot conclude with certainty that there is equal sensitivity to PGE of monocyte progenitor cells in the low and high DR+ fractions.
The relationship between HLA-DR antigen expression, commitment to monocyte differentiation, and colony inhibition by PGE was evaluated further by studying CFU-GM in CML, a stem cell disorder in which there is relative resistance to the inhibitory effects of PGE (30) (31) (32) (33) despite the presence of HLA-DR on virtually all CFU-GM (15) . In view of the selectivity of PGE for monocyte precursor cells, we considered the possibility that the lack of PGE inhibition in CML may be related to a relative decrease of monocyte colony-forming units in this disease. Previous investigators using other techniques to identify colony morphology including Luxol Fast Blue staining (32) and Giemsa staining (30, 31) Despite differences in the composition of CFU-GM subsets in NBM and CML, CFU-GM subsets from either source appeared to be inhibited by PGE to a similar degree, with granulocyte progenitor cells being least sensitive, and monocyte progenitor cells most sensitive, to PGE inhibition. In CML, however, the infrequency of monocyte progenitor cells makes it difficult 
